MedPath

KBIO INC.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website
https://kbio.com/

An Exploratory Study of ZB-06 as a Vaginal Contraceptive Film

Early Phase 1
Completed
Conditions
Contraception
Interventions
First Posted Date
2021-02-01
Last Posted Date
2025-01-15
Lead Sponsor
KBio Inc
Target Recruit Count
20
Registration Number
NCT04731818
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Eastern Virginia Medical School, Norfolk, Virginia, United States

KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers

Phase 1
Completed
Conditions
Covid19
Interventions
Biological: Low Dose of KBP-COVID-19
Biological: Placebo
Biological: High Dose of KBP-COVID-19
First Posted Date
2020-07-16
Last Posted Date
2025-05-18
Lead Sponsor
KBio Inc
Target Recruit Count
102
Registration Number
NCT04473690
Locations
๐Ÿ‡บ๐Ÿ‡ธ

PanAmerican Clinical Research, Brownsville, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Palm Beach Research Center, West Palm Beach, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

DM Clinical Research, Tomball, Texas, United States

and more 4 locations

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

Phase 1
Completed
Conditions
Influenza
Interventions
Biological: High dose
Biological: Placebo
Biological: Intermediate dose
Biological: Low dose
First Posted Date
2020-06-19
Last Posted Date
2021-09-16
Lead Sponsor
KBio Inc
Target Recruit Count
120
Registration Number
NCT04439695
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Meridian Clinical Research, Omaha, Nebraska, United States

Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV

Phase 1
Completed
Conditions
HIV
Herpes Simplex Infections
Interventions
Drug: Placebo Film
First Posted Date
2015-10-19
Last Posted Date
2023-11-14
Lead Sponsor
KBio Inc
Target Recruit Count
38
Registration Number
NCT02579083
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The Miriam Hospital, Providence, Rhode Island, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath